The Bayer Activities of Daily Living Scale (B-ADL)

The Bayer Activities of Daily Living Scale (B-ADL) has been developed on an international basis to assess deficits in the performance of everyday activities. The scale’s main target group is community dwelling patients who suffer mild cognitive impairment or mild-to-moderate dementia. It comprises 25 items and takes the form of a questionnaire to be completed by a caregiver or other informant sufficiently familiar with the patient. Statistical, clinical and domain-related criteria were used to select items from among a large number of activities of daily living (ADL) questions field tested in pilot studies in the USA, Germany, UK, Russia and Greece. The items included in the B-ADL have been chosen for their sensitivity to cognitive impairment, simplicity of concept, international applicability and their relevance to patients coping with the demands of everyday life. The scale uses items which reflect a wide range of domains. On account of its brevity, it is thought especially suitable for application within a GP and primary care context for both screening a patient’s ADL capacities as well as for documentation of treatment effects and the progress of dementia. This paper focuses on a description of the scale and its application.

[1]  B. Reisberg,et al.  The Global Deterioration Scale for assessment of primary degenerative dementia. , 1982, The American journal of psychiatry.

[2]  R. Brislin.  The wording and translation of research instruments. , 1986 .

[3]  A. Korten,et al.  Assessment of Cognitive Decline in the Elderly by Informant Interview , 1988, British Journal of Psychiatry.

[4]  J. Morris,et al.  Very mild senile dementia of the Alzheimer type. I. Clinical assessment. , 1989, Archives of neurology.

[5]  Recommendations for Clinical Drug Trials in Dementia , 1990 .

[6]  Daniel Commenges,et al.  Instrumental Activities of Daily Living as a Screening Tool for Cognitive Impairment and Dementia in Elderly Community Dwellers , 1992, Journal of the American Geriatrics Society.

[7]  N. Sartorius,et al.  Translation of Health Status Instruments , 1994 .

[8]  On the paradox of improving sensitivity of ADL scales for the detection of behavioral changes in early dementia. , 1994, International psychogeriatrics.

[9]  S. Finkel,et al.  Aging, health, and healing , 1995 .

[10]  S. Finkel,et al.  The Use of Clinical Experience to Stage the Severity of Functional Impairments in Alzheimer's Disease , 1996 .

[11]  J Huff,et al.  Activities of daily living as an outcome measure in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. , 1997, Alzheimer disease and associated disorders.

[12]  L. Nyberg,et al.  “Stops walking when talking” as a predictor of falls in elderly people , 1997, The Lancet.

[13]  M. Sano,et al.  An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimer's Disease , 1997, Alzheimer disease and associated disorders.

[14]  Tau Fluvalinate,et al.  The European Agency for the Evaluation of Medicinal Products , 1997 .

[15]  B. Reisberg,et al.  Informant-rated activities-of-daily-living (ADL) assessments: results of a study of 141 items in the U.S.A., Germany, Russia, and Greece from the International ADL Scale Development Project. , 1997, Alzheimer disease and associated disorders.